Cwestiwn ysgrifenedig WQ93632
- Gofynnwyd gan
- Sam RowlandsCeidwadwyr
- I'w ateb gan
- Cabinet Secretary for Health and Social Care
- Cyflwynwyd
- Dyddiad ateb
- Atebwyd
- Amser i'w ateb
- 8 diwrnod
Cwestiwn
Mae'r cwestiwn a'r ateb yn Saesneg gan nad oes fersiwn Gymraeg ar gael.
What is the Welsh Government doing to keep GPs apprised of the availability of HRT?
Ateb
Atebwyd gan Cabinet Secretary for Health and Social Care
Maintaining the continuity of supply of medicines to the UK is a reserved matter and is the responsibility of the UK Government. However, managing the implications of supply disruptions requires co-ordinated action between the UK and devolved governments and the NHS. My officials are working closely with their counterparts in the UK Government, as well as manufacturers, wholesalers, prescribers, and pharmacies to mitigate the effect of any disruption.
The extensive measures taken by the Welsh and UK governments to support pharmacists, prescribers and patients to manage HRT shortages were set out in a written statement issued by the former Cabinet Secretary for Health and Social Care on 18 October 2023, which is available at: https://www.gov.wales/written-statement-disruptions-supply-medicines
A range of Serious Shortage Protocols (SSP) for HRT medicines were put in place last year allowing pharmacists to supply clinically appropriate alternative HRT medicines when those prescribed are unavailable without the need for people having to return to their prescriber. All of these SSPs have been withdrawn, reflecting improved availability of HRT medicines.
Occasionally, the NHS experiences temporary shortages of specific medicines and the disruption to the supply of these is unsettling for those who have been prescribed them. GPs and community pharmacies are informed of these by way of a medicines shortage letter providing advice on the mitigating actions that need to be taken during the supply disruption.
There are currently known supply issues for two HRT products:
• FemSeven Sequi patches – anticipated re-supply date January 2025
• Indivina 1mg/2.5mg tablets – anticipated re-supply date October 2024
NHS Wales has been informed of the supply disruption to these HRT products and been advised of mitigating actions. A number of alternative HRT preparations are available and anyone having difficulty obtaining any treatment should contact their doctor or pharmacist to discuss a suitable alternative.
The Welsh Government’s Medicines Shortages web page offers general advice about why shortages occur and how they are managed https://www.gov.wales/medicines-shortages-0 and https://www.llyw.cymru/prinder-meddyginiaethau-0